The contribution of implantable cardioverter defibrillators to systemic inflammation in heart failure patients
Heart failure (HF) is associated with an increased inflammatory burden, which is manifested by the elevation of serum levels of some inflammatory mediators such C-reactive protein (CRP), cytokines. In addition, high levels of inflammatory markers in patients with HF have been associated with poor ou...
Main Authors: | Ozcan Orscelik, Bugra Ozkan, Mert Koray Ozcan |
---|---|
Format: | Article |
Language: | English |
Published: |
Society of Turaz Bilim
2019-06-01
|
Series: | Medicine Science |
Subjects: | |
Online Access: | http://www.ejmanager.com/fulltextpdf.php?mno=10986 |
Similar Items
-
Incidence, Predictors, and Outcomes of Implantable Cardioverter‐Defibrillator Discharge Among People Living With HIV
by: Raza M. Alvi, et al.
Published: (2018-09-01) -
Embodied Revelation: A Classic Grounded Theory of Heart Failure Patient Decision Making Surrounding Primary Prevention Implantable Cardioverter Defibrillator Therapy
by: Vera Barton-Caro Ph.D.,
Published: (2015-12-01) -
Implantable cardioverter-defibrillator programming after first occurrence of ventricular tachycardia in the Multicenter Automatic Defibrillator Implantation Trial–Reduce Inappropriate Therapy (MADIT-RIT)Key Findings
by: Mehmet K. Aktas, MD, MBA, FHRS, et al.
Published: (2020-06-01) -
Depressive Symptoms and Quality of Life in Patients With Heart Failure and an Implantable Cardioverter-Defibrillator
by: Christos Zormpas, et al.
Published: (2022-06-01) -
Implantable cardioverter-defibrillators step by step : an illustrated guide /
by: 439461 Stroobandt, Roland X., et al.
Published: (2009)